Search Results - "Rosko, Ashley Elizabeth"
-
1
Clinicopathologic features and outcomes associated with induction regimen intensity among older veterans with myeloma
Published in Journal of clinical oncology (01-06-2023)“…e20054 Background: More than one third of patients diagnosed with multiple myeloma (MM) are 75 years or older. Though registries and clinical trials have…”
Get full text
Journal Article -
2
Healthy lifestyle challenges among older female cancer survivors
Published in Journal of clinical oncology (10-10-2020)“…Abstract only 156 Background: Healthy lifestyles including consuming a healthy diet, being physically active, and maintaining a normal weight can improve…”
Get full text
Journal Article -
3
Step-up titration dosing (TD) of carfilzomib (K) is associated with prolonged duration of therapy and improved treatment outcomes compared to standard dosing (SD) in patients with multiple myeloma (MM)
Published in Journal of clinical oncology (01-06-2022)“…e20016 Background: K is a 2nd-generation proteasome inhibitor (PI) approved for the treatment of multiple myeloma (MM). K-based regimens are associated with…”
Get full text
Journal Article -
4
Patterns of physical and mental health well-being in older female cancer survivors
Published in Journal of clinical oncology (10-10-2020)“…Abstract only 173 Background: The majority of cancer survivors are older adults (≥65 years), but their lifestyle behaviors are understudied. Factors associated…”
Get full text
Journal Article -
5
Race as a predictor of outcome in young patients with myeloma
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e20019 Background: Multiple myeloma (MM) is a malignancy that affects Black Americans (BA) more often and at earlier age than White Americans…”
Get full text
Journal Article -
6
Daratumumab-induced lymphopenia predicts adverse events and outcomes in patients with myeloma
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e20534 Background: Daratumumab, a monoclonal antibody against CD38, is very effective in patients with Multiple Myeloma (MM). CD38 is expressed…”
Get full text
Journal Article -
7
Autologous stem cell transplant (ASCT) in myeloma to improve patient reported physical function and fatigue
Published in Journal of clinical oncology (20-05-2017)“…Abstract only 10044 Background: Patients with Multiple Myeloma (MM) report some of the poorest Health-related quality of life (HRQoL). Few studies show how…”
Get full text
Journal Article -
8
Is immunotherapy toxicity associated with improved overall survival among older adults with advanced cancer?
Published in Journal of clinical oncology (20-05-2019)“…Abstract only 6580 Background: There is growing evidence that checkpoint inhibitor immunotherapy (IO) toxicity is associated with improved treatment response…”
Get full text
Journal Article -
9
A feasibility study of electronic geriatric assessment for real-time morbidity evaluation
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article